Information about Rixpharma
My details
*
*
*

Rixpharma (SRL)

BE 0882.172.240

Avenue John Kennedy 45, 1330 Rixensart

Company information

Status
Active

Enterprise number

BE0882.172.240

VAT liability
No
Established
26-06-2006
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Other software publishing
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Rixpharma

2024 2023 2022 2021
Profit/Loss € -3,643 -150 % € 7,253 272 % € -4,213 -11 % € -3,779
Equity € 113,032 -3 % € 116,676 7 % € 109,422 -4 % € 113,635
Gross margin € -3,256 -139 % € 8,254 2 % € 8,082 -2 % € 8,283

Publications from Rixpharma

Date Publication
03-04-2024 Articles of Association (Translation, Coordination, Other Modifications,...) (FR)
29-01-2014 Goal - Capital, Shares - Articles of Association (Translation, Coordination, Other Modifications, …) (FR)
11-01-2012 Resignations, Appointments (FR)
11-07-2006 Constitution (FR)

Frequently asked questions

What is the enterprise number of Rixpharma?
The enterprise number of Rixpharma is BE 0882.172.240.
Wat is the PEPPOL ID of Rixpharma?
There is no information available about the PEPPOL ID of Rixpharma or the company is not yet registered on the PEPPOL network.
When was Rixpharma founded?
Rixpharma was founded on 26-06-2006.
What is the address of Rixpharma?
The current registered office of Rixpharma is located at Avenue John Kennedy 45, 1330 Rixensart.
When was the last time Rixpharma filed their annual financial statements?
The most recent financial statements of Rixpharma were filed on 08-09-2025.
How many employees does Rixpharma have?
There are currently no employees working at Rixpharma or no workforce information is available.
What is the annual turnover of Rixpharma?
At the time of its most recent financial statements, Rixpharma did not publish any turnover figures. Rixpharma reported a gross margin of -€3,256.26.

Sources